Treatment of hypermyoglobinemia after CRS plus HIPEC for patients with peritoneal carcinomatosis: A retrospective comparative study

被引:7
|
作者
Liu, Gang [1 ]
Ji, Zhong-He [1 ]
Yu, Yang [1 ]
Li, Xin-Bao [1 ]
Zhang, Yan-Bin [1 ]
Peng, Kai-Wen [1 ]
Li, Yan [1 ]
机构
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Peritoneal Canc Surg, 10 Tieyi Rd,Yangfangdian St, Beijing 100038, Peoples R China
关键词
cytoreductive surgery; hypermyoglobinemia; hyperthermic intraperitoneal chemotherapy; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; EPITHELIAL OVARIAN-CANCER; ACUTE KIDNEY INJURY; CYTOREDUCTIVE SURGERY; PSEUDOMYXOMA PERITONEI; COLORECTAL-CANCER; CHINESE CENTER; MYOGLOBIN; TRIAL;
D O I
10.1097/MD.0000000000008573
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This retrospective comparative study aims to explore the time courses of serum myoglobin (Mb) changes, and summarize our experience in treating patients with hypermyoglobinemia after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).This study covered 60 patients with peritoneal carcinomatosis treated with CRS + HIPEC as the study group, and another 25 cancer patients treated with conventional extensive surgery without HIPEC as the control group from February to October 2016. In the study group, patients with postoperative hypermyoglobinemia were on a comprehensive treatment regimen consisting intravenous injection of sodium bicarbonate solution according to the Mb level. In the control group, patients were recorded and treated with the same regimen except for special sodium bicarbonate solution. The preoperative and postoperative serum Mb, blood urine nitrogen (BUN), and creatinine (Cr) levels were evaluated.There were no significantly difference between the 2 groups in serum Mb, BUN, and Cr levels before surgery. Postoperative serum Mb levels were elevated in both groups and significantly higher on postoperative 0 to 2 days (P<.05) in the study group than the control group. The peak value of serum Mb levels (426.65108.386 g/L) occurred on the surgery day. The serum Mb change rate was much bigger in the study group than the control group. Serum BUN levels in both groups revealed a slow increase during the early postoperative period and were significantly lower in the study group than the control group on days 1 and 2. The serum Cr levels were similar and stable between the 2 groups after surgery. The serum Cr change rates changed synchronously with same tendency in both groups, and on postoperative day 1 the increase rate was bigger in the control group than the study group.Hypermyoglobinemia is a common and prominent lab abnormality after CRS + HIPEC, and serum Mb levels could be an early and sensitive indicator for dramatic disturbances in the internal milieu after CRS + HIPEC. Adequate treatment with sodium bicarbonate could accelerate the reduction in serum Mb levels and reduce the risk for major organ damages.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] EAssessment of Fertility Following CRS/HIPEC for the Management of Peritoneal Carcinomatosis: A Single Institution Experience
    Schlegel, C.
    Liebdzinski, M. R.
    Hall, L.
    Pingpank, J.
    Holtzman, M.
    Lee, A.
    Bartlett, D.
    Choudry, M.
    Ongchin, M.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S114 - S114
  • [22] The use of Oxaliplatin or Mitomycin C in HIPEC treatment for peritoneal carcinomatosis from colorectal cancer: A comparative study
    Hompes, D.
    D'Hoore, A.
    Wolthuis, A.
    Fieuws, S.
    Mirck, B.
    Bruin, S.
    Verwaal, V.
    JOURNAL OF SURGICAL ONCOLOGY, 2014, 109 (06) : 527 - 532
  • [23] CRS and HIPEC for patients with peritoneal metastases of gastric cancer
    Brandl, A.
    Raue, W.
    Reich, J.
    Pratschke, J.
    Raue, B.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 83 - 83
  • [24] Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal carcinomatosis arising from gastric cancer
    Piso, P.
    Glockzin, G.
    Schlitt, H. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [25] Cytoreduction and HIPEC in the treatment of "unconventional" secondary peritoneal carcinomatosis
    Cardi, Maurizio
    Sammartino, Paolo
    Mingarelli, Valentina
    Sibio, Simone
    Accarpio, Fabio
    Biacchi, Daniele
    Musio, Daniela
    Sollazzo, Bianca
    Di Giorgio, Angelo
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2015, 13 : 1
  • [26] Cytoreduction and HIPEC in the treatment of “unconventional” secondary peritoneal carcinomatosis
    Maurizio Cardi
    Paolo Sammartino
    Valentina Mingarelli
    Simone Sibio
    Fabio Accarpio
    Daniele Biacchi
    Daniela Musio
    Bianca Sollazzo
    Angelo Di Giorgio
    World Journal of Surgical Oncology, 13
  • [27] Survival after CRS/HIPEC for colorectal and appendicular peritoneal malignancy
    Lehmann, K.
    Eshmuminov, D.
    Sarvan, M.
    Vonlanthen, R.
    Gertsch, P.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 8 - 8
  • [28] Survival after CRS/HIPEC for colorectal and appendicular peritoneal malignancy
    Schneider, Marcel
    Eshmuminov, Dilmurod
    Vonlanthen, Rene
    Gertsch, Philippe
    Lehmann, Kuno
    SWISS MEDICAL WEEKLY, 2015, 145 : S4 - S4
  • [29] Circulating tumor cells as biomarkers in patients with peritoneal carcinomatosis of colon cancer origin treated with cytoreductive surgery plus intraoperative hyperthermic intraperitoneal chemotherapy procedure (CRS plus HIPEC)
    Serrano, M. J.
    Torres-Melero, J.
    Ortega, F. G.
    Morales Gonzalez, A.
    Lorente, J. A.
    Garcia-Puche, J. L.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S398 - S398
  • [30] Peritoneal Carcinomatosis in the Elderly: Too Old for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS/ HIPEC)?
    Yudegarynia, Sina
    Hernandez, Alexandra
    Montealegre, Mariaugusta
    Cash, Charles
    Gomez, Kimberly P.
    Joshi, Priyashma
    Noe, Daniel G.
    Bahna, Heidi
    Moller, Mecker
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S233 - S233